Sun Pharmaceutical Industries Limited

This study is testing an investigational weekly injection called GL0034 for adults with type 2 diabetes who are also overweight or obese. The main goal is to see if the treatment can lower long-term blood sugar levels (HbA1c) and help with weight loss over 36 weeks. Participants …

This early-stage study aims to understand how kidney function affects the body's processing of a new long-acting diabetes drug called GL0034. Researchers will give a single dose to about 40 adults with varying levels of kidney health, from normal to severe impairment. The goal is…

This study aims to understand the safety of the medication tildrakizumab during pregnancy. Researchers will follow 200 pregnant women who are taking the drug for approved skin conditions and compare their pregnancy and infant outcomes to similar women not taking the drug. The goa…